Search
for

    Sort by

    Research 30 of 31

    1. Alopecia induced by dopamine agonists Neurology · 2002 · 21 citations
    2. Telogen effluvium associated with the dopamine agonist pramipexole in a 55-year-old woman with Parkinson's disease Journal of The American Academy of Dermatology · 2006 · 14 citations
    3. Mutation in 5′ upstream region of <i>GCH</i> I gene causes familial dopa-responsive dystonia Movement Disorders · 2011 · 7 citations
    4. Prednisolone Reactions Weekly · 2006
    5. Pramipexole Elsevier eBooks · 2015
    6. Drug Reactions Affecting Hair: Diagnosis Dermatologic Clinics · 2007 · 85 citations
    7. Recent advances in microneedle composites for biomedical applications: Advanced drug delivery technologies Materials Science and Engineering: C · 2019 · 64 citations
    8. Kin‐cohort analysis of <i>LRRK2</i>‐G2019S penetrance in Parkinson's disease Movement Disorders · 2011 · 47 citations
    9. A preliminary study of finasteride in Tourette syndrome Movement Disorders · 2011 · 46 citations
    10. Desferrioxamine treatment of aceruloplasminemia: Long‐term follow‐up Movement Disorders · 2011 · 39 citations
    11. Parkinson's disease and skin 2021 · 28 citations
    12. Management of the psychological comorbidities of dermatological conditions: practitioners&#39; guidelines Clinical, Cosmetic and Investigational Dermatology · 2017 · 23 citations
    13. Pathological findings in a case of stiff person syndrome with anti‐GAD antibodies Movement Disorders · 2011 · 17 citations
    14. Applications and Implications of Heparin and Protamine in Tissue Engineering and Regenerative Medicine BioMed Research International · 2014 · 15 citations
    15. Formulation and Characterization of Transethosomes for Enhanced Transdermal Delivery of Propranolol Hydrochloride Micro and Nanosystems · 2020 · 11 citations
    16. Frontotemporal dementia with parkinsonism presenting as posterior cortical atrophy Movement Disorders · 2011 · 4 citations
    17. Chemically Induced Hair Loss/Alopecia Springer eBooks · 2019
    18. Drugs that affect autonomic functions or the extrapyramidal system Side effects of drugs annual · 2009
    19. Finasteride appears to be associated with an increased incidence of sexual dysfunction Reactions Weekly · 2003
    20. Hair loss, old and uninterested nonmotor symptom in Parkinson’s disease during dopaminergic therapy Journal of movement disorders · 2023
    21. WARFARIN 2010
    22. Advances in Chitosan-Based Nanoparticles for Drug Delivery International Journal of Molecular Sciences · 2021 · 96 citations
    23. Recent Advances in the Structural Design of Photosensitive Agent Formulations Using “Soft” Colloidal Nanocarriers Pharmaceutics · 2020 · 54 citations
    24. Electroosmotic pore transport in human skin. Pharmaceutical Research · 2003 · 47 citations
    25. An overview of current strategies and future prospects in drug repurposing in tuberculosis Exploration of Medicine · 2023 · 7 citations
    26. Combined drug triads for synergic neuroprotection in retinal degeneration Biomedicine & pharmacotherapy · 2022 · 6 citations
    27. Nanoemulgel: For Promising Topical and Systemic Delivery IntechOpen eBooks · 2022 · 5 citations
    28. <i>Nigella sativa</i> and its nano‐mediated approach toward management of neurodegenerative disorders: A review Ibrain · 2023 · 1 citations
    29. Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system Medicine · 2026
    30. “Doctor, You Must Examine My Creature Collection!”: A Case Report of Delusional Infestation Cureus · 2022